{
    "id": "72d78298-266a-45d6-9577-b4f3737134ab",
    "indications": "therapy lipid-altering agents one component multiple risk factor intervention individuals significantly increased risk atherosclerotic vascular disease due hypercholesterolemia . therapy indicated adjunct diet response diet restricted saturated fat cholesterol nonpharmacologic measures alone inadequate .",
    "contraindications": "adults : recommended starting dose 40 mg daily . 80 mg dose patients reaching ldl-c goal 40 mg. ( 2.2 ) significant renal impairment : recommended starting dose pravastatin 10 mg daily . ( 2.3 ) children ( ages 8 13 years , inclusive ) : recommended starting dose 20 mg daily . ( 2.4 ) adolescents ( ages 14 18 years ) : recommended starting dose 40 mg daily . ( 2.4 )",
    "warningsAndPrecautions": "16.1 supplied pravastatin sodium tablets , usp supplied : 40 mg tablets : white off-white , rounded , rectangular-shaped , biconvex tablets debossed “ b 40 ” one side plain side . ndc 72162-1953-0 : 1000 tablets bottle 16.2 storage store 25°c ( 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] . keep tightly closed ( protect moisture ) . protect light . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "hypersensitivity component medication . ( 4.1 , 6.2 , 11 ) active liver disease unexplained , persistent elevations serum transaminases . ( 4.2 , 5.3 ) pregnancy ( 4.3 , 8.1 , 8.3 ) lactation ( 4.4 , 8.2 )",
    "ingredients": [
        {
            "name": "PRAVASTATIN SODIUM",
            "code": "3M8608UQ61"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM OXIDE",
            "code": "3A3U0GI71G"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        }
    ],
    "organization": "Bryant Ranch Prepack",
    "name": "PRAVASTATIN SODIUM",
    "effectiveTime": "20250519",
    "indications_original": "Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate.",
    "contraindications_original": "Adults: the recommended starting dose is 40 mg once daily. Use 80 mg dose only for patients not reaching LDL-C goal with 40 mg. (2.2) Significant renal impairment: the recommended starting dose is pravastatin 10 mg once daily. (2.3) Children (ages 8 to 13 years, inclusive): the recommended starting dose is 20 mg once daily. (2.4) Adolescents (ages 14 to 18 years): the recommended starting dose is 40 mg once daily. (2.4)",
    "warningsAndPrecautions_original": "16.1 How Supplied\n                  \n                  \n                     Pravastatin Sodium Tablets, USP are supplied as:\n                  \n                     40 mg tablets: White to off-white, rounded, rectangular-shaped, biconvex tablets debossed with “B 40” on one side and plain on other side.\n                  \n                     NDC 72162-1953-0: 1000 Tablets in a BOTTLE\n                  \n                  \n                     16.2 Storage\n                  \n                  Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Keep tightly closed (protect from moisture). Protect from light.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Hypersensitivity to any component of this medication. (4.1, 6.2, 11) Active liver disease or unexplained, persistent elevations of serum transaminases. (4.2, 5.3 ) Pregnancy (4.3, 8.1, 8.3) Lactation (4.4, 8.2)"
}